Clinical Trial Update: Doxorubicin Hydrochloride, Cyclophosphamide, Docetaxel, and S-1 Before Surgery in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 trial from Yonsei University evaluates a neoadjuvant regimen of doxorubicin hydrochloride, cyclophosphamide, docetaxel, and S-1 before surgery in w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• DOXORUBICIN HYDROCHLORIDE (Doxorubicin hydrochloride)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Yonsei University | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN